L
Linda S. Elting
Researcher at University of Texas MD Anderson Cancer Center
Publications - 203
Citations - 19126
Linda S. Elting is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 63, co-authored 199 publications receiving 17485 citations. Previous affiliations of Linda S. Elting include University of Texas at Austin & University of Texas System.
Papers
More filters
Journal ArticleDOI
Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors
TL;DR: In this paper, the incidence of viridans streptococcal bacteremia at the University of Texas M D Anderson Cancer Center in Houston increased from one case per 10,000 admissions to 47 cases per 1000 admissions.
Journal ArticleDOI
Pseudomonas bacteremia. Retrospective analysis of 410 episodes.
TL;DR: Patients with shock, pneumonia, or persistent neutropenia had a substantially poorer prognosis and patients who received an antipseudomonal β-lactam antibiotic with or without an aminoglycoside had a significantly higher cure rate.
Journal ArticleDOI
Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment
TL;DR: Current knowledge of bisphosphonate-associated osteonecrosis, a new oral complication in oncology, is presented and pathobiology, clinical features, management, and future directions for the disorder are discussed.
Journal ArticleDOI
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life
Siri Beier Jensen,Anne Marie Lynge Pedersen,Arjan Vissink,Elo Andersen,C. G. Brown,Andrew Davies,J. Dutilh,Janet S. Fulton,Ljiljana Janković,Nilza Nelly Fontana Lopes,A. L. S. Mello,L. V. Muniz,C. A. Murdoch-Kinch,Raj G. Nair,Joel J. Napeñas,A. Nogueira-Rodrigues,Deborah P. Saunders,B. Stirling,I. von Bültzingslöwen,Dianna Weikel,Linda S. Elting,Frederik Spijkervet,Michael T. Brennan +22 more
TL;DR: Salivary gland hypofunction and xerostomia are induced by radiotherapy in the head and neck region depending on the cumulative radiation dose to the gland tissue, and treatment focus should be on optimized/new approaches to further reduce the doses to the parotids.
Journal ArticleDOI
Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: Demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life
Linda S. Elting,Dorothy M. K. Keefe,Stephen T. Sonis,Adam S. Garden,Fred K. L. Spijkervet,Andrei Barasch,Roy B. Tishler,Thomas P. Canty,Mahesh K. Kudrimoti,Montserrat Vera-Llonch +9 more
TL;DR: The risk, severity, and patient-reported outcomes of radiation-induced mucositis among head and neck cancer patients were prospectively estimated in this article, and the detrimental effects on QOL and functional status are significant, and opioid analgesia provides inadequate relief.